Published in Nanomedicine on February 18, 2010
Silica coating influences the corona and biokinetics of cerium oxide nanoparticles. Part Fibre Toxicol (2015) 1.45
SOD therapeutics: latest insights into their structure-activity relationships and impact on the cellular redox-based signaling pathways. Antioxid Redox Signal (2013) 1.29
Cerium oxide nanoparticles inhibit oxidative stress and nuclear factor-κB activation in H9c2 cardiomyocytes exposed to cigarette smoke extract. J Pharmacol Exp Ther (2011) 1.08
Radiation damage and radioprotectants: new concepts in the era of molecular medicine. Br J Radiol (2012) 1.05
Cerium oxide nanoparticles: potential applications for cancer and other diseases. Am J Transl Res (2013) 1.03
Sensitization of pancreatic cancer cells to radiation by cerium oxide nanoparticle-induced ROS production. Nanomedicine (2012) 1.01
Nanoceria: a rare-earth nanoparticle as a novel anti-angiogenic therapeutic agent in ovarian cancer. PLoS One (2013) 0.96
Toxicological evaluations of rare earths and their health impacts to workers: a literature review. Saf Health Work (2013) 0.91
Cerium oxide nanoparticles in cancer. Onco Targets Ther (2014) 0.88
Antibacterial activity of polymer coated cerium oxide nanoparticles. PLoS One (2012) 0.87
Immunomodulation and T helper TH₁/TH₂ response polarization by CeO₂ and TiO₂ nanoparticles. PLoS One (2013) 0.86
Gold nanoparticles - the theranostic challenge for PPPM: nanocardiology application. EPMA J (2013) 0.85
Antitumor Activities of Metal Oxide Nanoparticles. Nanomaterials (Basel) (2015) 0.83
Cerium Dioxide Nanoparticle Exposure Improves Microvascular Dysfunction and Reduces Oxidative Stress in Spontaneously Hypertensive Rats. Front Physiol (2015) 0.83
Catalytic Properties and Biomedical Applications of Cerium Oxide Nanoparticles. Environ Sci Nano (2015) 0.83
Antioxidant Cerium Oxide Nanoparticles in Biology and Medicine. Antioxidants (Basel) (2016) 0.82
Convergence of nanotechnology with radiation therapy-insights and implications for clinical translation. Transl Cancer Res (2013) 0.82
The Effect of Cerium Oxide Nanoparticle Valence State on Reactive Oxygen Species and Toxicity. Biol Trace Elem Res (2015) 0.82
Dawn of advanced molecular medicine: nanotechnological advancements in cancer imaging and therapy. Crit Rev Oncog (2014) 0.81
Potential of using cerium oxide nanoparticles for protecting healthy tissue during accelerated partial breast irradiation (APBI). Phys Med (2016) 0.80
Cerium oxide nanoparticles protect rodent lungs from hypobaric hypoxia-induced oxidative stress and inflammation. Int J Nanomedicine (2013) 0.80
Enhancement of radiotherapy by ceria nanoparticles modified with neogambogic acid in breast cancer cells. Int J Nanomedicine (2015) 0.79
Cytotoxicity and antibacterial activity of gold-supported cerium oxide nanoparticles. Int J Nanomedicine (2014) 0.79
Intracellular signal modulation by nanomaterials. Adv Exp Med Biol (2014) 0.78
Real-time monitoring of superoxide accumulation and antioxidant activity in a brain slice model using an electrochemical cytochrome c biosensor. Free Radic Biol Med (2012) 0.78
Cerium oxide nanoparticles inhibit the migration and proliferation of gastric cancer by increasing DHX15 expression. Int J Nanomedicine (2016) 0.75
Evaluation of in vitro cytotoxicity, biocompatibility, and changes in the expression of apoptosis regulatory proteins induced by cerium oxide nanocrystals. Sci Technol Adv Mater (2017) 0.75
Nanoparticles and direct immunosuppression. Exp Biol Med (Maywood) (2016) 0.75
Cationic lipid-nanoceria hybrids, a novel nonviral vector-mediated gene delivery into mammalian cells: investigation of the cellular uptake mechanism. Sci Rep (2016) 0.75
Beneficial effects of cerium oxide nanoparticles in development of chondrocyte-seeded hydrogel constructs and cellular response to interleukin insults. Tissue Eng Part A (2014) 0.75
Non-toxic retention of nanoceria in murine eyes. Mol Vis (2016) 0.75
Evaluation of the effect of valence state on cerium oxide nanoparticle toxicity following intratracheal instillation in rats. Nanotoxicology (2016) 0.75
Cerium Oxide Nanoparticles: A Potential Medical Countermeasure to Mitigate Radiation-Induced Lung Injury in CBA/J Mice. Radiat Res (2016) 0.75
The effect of low concentrations of nanocrystalline cerium dioxide on the embryotoxicity of doxorubicin for fish. Dokl Biol Sci (2012) 0.75
Rare earth nanoparticles prevent retinal degeneration induced by intracellular peroxides. Nat Nanotechnol (2006) 3.30
Vacancy engineered ceria nanostructures for protection from radiation-induced cellular damage. Nano Lett (2005) 2.71
Auto-catalytic ceria nanoparticles offer neuroprotection to adult rat spinal cord neurons. Biomaterials (2007) 2.62
Evaluation of high ipsilateral subventricular zone radiation therapy dose in glioblastoma: a pooled analysis. Int J Radiat Oncol Biol Phys (2013) 2.61
International validation of a preoperative nomogram for prostate cancer recurrence after radical prostatectomy. J Clin Oncol (2002) 2.51
Superoxide dismutase mimetic properties exhibited by vacancy engineered ceria nanoparticles. Chem Commun (Camb) (2007) 2.42
Protein adsorption and cellular uptake of cerium oxide nanoparticles as a function of zeta potential. Biomaterials (2007) 2.19
Stereotactic body radiotherapy for localized prostate cancer: pooled analysis from a multi-institutional consortium of prospective phase II trials. Radiother Oncol (2013) 2.15
Inhibition of SRC expression and activity inhibits tumor progression and metastasis of human pancreatic adenocarcinoma cells in an orthotopic nude mouse model. Am J Pathol (2006) 2.07
The role of cerium redox state in the SOD mimetic activity of nanoceria. Biomaterials (2008) 2.04
A preoperative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancer. J Urol (2003) 1.96
The role of overall treatment time in the outcome of radiotherapy of prostate cancer: an analysis of biochemical failure in 4839 men treated between 1987 and 1995. Radiother Oncol (2010) 1.87
Anti-inflammatory properties of cerium oxide nanoparticles. Small (2009) 1.86
Tolfenamic acid and pancreatic cancer growth, angiogenesis, and Sp protein degradation. J Natl Cancer Inst (2006) 1.83
Health-related quality of life after stereotactic body radiation therapy for localized prostate cancer: results from a multi-institutional consortium of prospective trials. Int J Radiat Oncol Biol Phys (2013) 1.77
Comparison of alternative biochemical failure definitions based on clinical outcome in 4839 prostate cancer patients treated by external beam radiotherapy between 1986 and 1995. Int J Radiat Oncol Biol Phys (2003) 1.65
Nanoceria exhibit redox state-dependent catalase mimetic activity. Chem Commun (Camb) (2010) 1.65
Regulation of vascular endothelial growth factor receptor-1 expression by specificity proteins 1, 3, and 4 in pancreatic cancer cells. Cancer Res (2007) 1.64
Expression and activity of SRC regulate interleukin-8 expression in pancreatic adenocarcinoma cells: implications for angiogenesis. Cancer Res (2005) 1.34
Differential effects of vascular endothelial growth factor receptor-2 inhibitor ZD6474 on circulating endothelial progenitors and mature circulating endothelial cells: implications for use as a surrogate marker of antiangiogenic activity. Clin Cancer Res (2005) 1.33
Ultralight multiwalled carbon nanotube aerogel. ACS Nano (2010) 1.32
Three-dimensional prostate position estimation with a single x-ray imager utilizing the spatial probability density. Phys Med Biol (2008) 1.28
Protection from radiation-induced pneumonitis using cerium oxide nanoparticles. Nanomedicine (2009) 1.22
Hypofractionation for prostate cancer. Cancer J (2009) 1.21
Effects of cerium oxide nanoparticles on the growth of keratinocytes, fibroblasts and vascular endothelial cells in cutaneous wound healing. Biomaterials (2012) 1.20
Combined cytotoxic and anti-invasive properties of redox-active nanoparticles in tumor-stroma interactions. Biomaterials (2011) 1.19
Bio-distribution and in vivo antioxidant effects of cerium oxide nanoparticles in mice. Environ Toxicol (2011) 1.17
PEGylated inorganic nanoparticles. Angew Chem Int Ed Engl (2011) 1.17
Bcl-B expression in human epithelial and nonepithelial malignancies. Clin Cancer Res (2008) 1.16
Unveiling the mechanism of uptake and sub-cellular distribution of cerium oxide nanoparticles. Mol Biosyst (2010) 1.15
c-Src regulates constitutive and EGF-mediated VEGF expression in pancreatic tumor cells through activation of phosphatidyl inositol-3 kinase and p38 MAPK. Pancreas (2005) 1.14
Cerium oxide nanoparticles scavenge nitric oxide radical (˙NO). Chem Commun (Camb) (2012) 1.13
AP23846, a novel and highly potent Src family kinase inhibitor, reduces vascular endothelial growth factor and interleukin-8 expression in human solid tumor cell lines and abrogates downstream angiogenic processes. Mol Cancer Ther (2005) 1.13
Redox-active radical scavenging nanomaterials. Chem Soc Rev (2010) 1.12
Is year of radical prostatectomy a predictor of outcome in prostate cancer? J Urol (2004) 1.11
4π noncoplanar stereotactic body radiation therapy for centrally located or larger lung tumors. Int J Radiat Oncol Biol Phys (2013) 1.10
Review of image-guided radiation therapy. Expert Rev Anticancer Ther (2007) 1.09
Evaluation of image-guidance protocols in the treatment of head and neck cancers. Int J Radiat Oncol Biol Phys (2006) 1.09
Cerium oxide nanoparticles: applications and prospects in nanomedicine. Nanomedicine (Lond) (2013) 1.07
Downregulation of tumor growth and invasion by redox-active nanoparticles. Antioxid Redox Signal (2013) 1.07
Nanoceria inhibit the development and promote the regression of pathologic retinal neovascularization in the Vldlr knockout mouse. PLoS One (2011) 1.07
4π non-coplanar liver SBRT: a novel delivery technique. Int J Radiat Oncol Biol Phys (2012) 1.06
PEGylated nanoceria as radical scavenger with tunable redox chemistry. J Am Chem Soc (2009) 1.05
Levetiracetam enhances p53-mediated MGMT inhibition and sensitizes glioblastoma cells to temozolomide. Neuro Oncol (2010) 1.04
The induction of angiogenesis by cerium oxide nanoparticles through the modulation of oxygen in intracellular environments. Biomaterials (2012) 1.03
Nanoceria extend photoreceptor cell lifespan in tubby mice by modulation of apoptosis/survival signaling pathways. Neurobiol Dis (2011) 1.02
Blockade of the epidermal growth factor receptor signaling inhibits angiogenesis leading to regression of human renal cell carcinoma growing orthotopically in nude mice. Clin Cancer Res (2002) 1.02
Transforming growth factor alpha expression drives constitutive epidermal growth factor receptor pathway activation and sensitivity to gefitinib (Iressa) in human pancreatic cancer cell lines. Cancer Res (2006) 1.02
Exposure to titanium dioxide nanomaterials provokes inflammation of an in vitro human immune construct. ACS Nano (2009) 1.02
Quantitative and qualitative in vivo angiogenesis assay. Int J Oncol (2002) 1.02
Sensitization of pancreatic cancer cells to radiation by cerium oxide nanoparticle-induced ROS production. Nanomedicine (2012) 1.01
Expression of epidermal growth factor (EGF)/transforming growth factor-alpha by human lung cancer cells determines their response to EGF receptor tyrosine kinase inhibition in the lungs of mice. Mol Cancer Ther (2007) 1.00
Protonated nanoparticle surface governing ligand tethering and cellular targeting. ACS Nano (2009) 1.00
Tolfenamic acid decreases c-Met expression through Sp proteins degradation and inhibits lung cancer cells growth and tumor formation in orthotopic mice. Invest New Drugs (2009) 0.99
Sexuality and health-related quality of life after prostate cancer in African-American and white men treated for localized disease. J Sex Marital Ther (2004) 0.99
Prediction of intrafraction prostate motion: accuracy of pre- and post-treatment imaging and intermittent imaging. Int J Radiat Oncol Biol Phys (2008) 0.97
Cellular response of Shewanella oneidensis to strontium stress. Appl Environ Microbiol (2006) 0.97
Nanoceria: a rare-earth nanoparticle as a novel anti-angiogenic therapeutic agent in ovarian cancer. PLoS One (2013) 0.96
Multicolored redox active upconverter cerium oxide nanoparticle for bio-imaging and therapeutics. Chem Commun (Camb) (2010) 0.96
Cellular interaction and toxicity depend on physicochemical properties and surface modification of redox-active nanomaterials. ACS Nano (2013) 0.96
Tolfenamic acid enhances pancreatic cancer cell and tumor response to radiation therapy by inhibiting survivin protein expression. Mol Cancer Ther (2009) 0.94
Age and PSA predict likelihood of organ-confined disease in men presenting with PSA less than 10 ng/mL: implications for screening. Urology (2003) 0.94
Hydrophobic high surface area zeolites derived from fly ash for oil spill remediation. Environ Sci Technol (2013) 0.92
Sustained protection against photoreceptor degeneration in tubby mice by intravitreal injection of nanoceria. Biomaterials (2012) 0.92
Administration of optimal biological dose and schedule of interferon alpha combined with gemcitabine induces apoptosis in tumor-associated endothelial cells and reduces growth of human pancreatic carcinoma implanted orthotopically in nude mice. Clin Cancer Res (2003) 0.92
A phosphate-dependent shift in redox state of cerium oxide nanoparticles and its effects on catalytic properties. Biomaterials (2011) 0.92
Failure definition-dependent differences in outcome following radiation for localized prostate cancer: can one size fit all? Int J Radiat Oncol Biol Phys (2005) 0.92
Angiogenesis: an update and potential drug approaches (review). Int J Oncol (2010) 0.91
Fenton-like reaction catalyzed by the rare earth inner transition metal cerium. Environ Sci Technol (2008) 0.91
Bioluminescence imaging correlates with tumor progression in an orthotopic mouse model of lung cancer. Surg Oncol (2010) 0.91
Sustained inhibition of neovascularization in vldlr-/- mice following intravitreal injection of cerium oxide nanoparticles and the role of the ASK1-P38/JNK-NF-κB pathway. Biomaterials (2013) 0.91
Boron nitride nanotube reinforced hydroxyapatite composite: mechanical and tribological performance and in-vitro biocompatibility to osteoblasts. J Mech Behav Biomed Mater (2010) 0.90
Self-assembly of cerium oxide nanostructures in ice molds. Small (2008) 0.90
Nanoceria particles prevent ROI-induced blindness. Adv Exp Med Biol (2008) 0.90
Antibody-conjugated PEGylated cerium oxide nanoparticles for specific targeting of Aβ aggregates modulate neuronal survival pathways. Acta Biomater (2012) 0.89
Nanoceria inhibit expression of genes associated with inflammation and angiogenesis in the retina of Vldlr null mice. Exp Eye Res (2013) 0.89
Tolfenamic acid inhibits ovarian cancer cell growth and decreases the expression of c-Met and survivin through suppressing specificity protein transcription factors. Gynecol Oncol (2011) 0.89
Luminescence properties of europium-doped cerium oxide nanoparticles: role of vacancy and oxidation states. Langmuir (2009) 0.89
Catalytic nanoceria are preferentially retained in the rat retina and are not cytotoxic after intravitreal injection. PLoS One (2013) 0.88
Synergistic therapy of human ovarian carcinoma implanted orthotopically in nude mice by optimal biological dose of pegylated interferon alpha combined with paclitaxel. Clin Cancer Res (2002) 0.87
Antibacterial activity of polymer coated cerium oxide nanoparticles. PLoS One (2012) 0.87
Dopant-mediated oxygen vacancy tuning in ceria nanoparticles. Nanotechnology (2009) 0.86
Immunomodulation and T helper TH₁/TH₂ response polarization by CeO₂ and TiO₂ nanoparticles. PLoS One (2013) 0.86
A facile nanoparticle immunoassay for cancer biomarker discovery. J Nanobiotechnology (2011) 0.86
Harnessing nanoparticles to improve toxicity after head and neck radiation. Nanomedicine (2012) 0.86
High-resolution and analytical TEM investigation of metastable-tetragonal phase stabilization in undoped nanocrystalline zirconia. J Nanosci Nanotechnol (2004) 0.86
Long-term (10-year) gastrointestinal and genitourinary toxicity after treatment with external beam radiotherapy, radical prostatectomy, or brachytherapy for prostate cancer. Prostate Cancer (2012) 0.85
Tuning hydrated nanoceria surfaces: experimental/theoretical investigations of ion exchange and implications in organic and inorganic interactions. Langmuir (2010) 0.85
A metastatic colon cancer model using nonoperative transanal rectal injection. Surg Endosc (2009) 0.85
Blockade of MGMT expression by O6 benzyl guanine leads to inhibition of pancreatic cancer growth and induction of apoptosis. Clin Cancer Res (2009) 0.85
Hierarchical assembly of inorganic nanostructure building blocks to octahedral superstructures-a true template-free self-assembly. Nanotechnology (2007) 0.85